FREE CASE EVALUATION: +1-888-885-2771                                          Email us:


L’Oreal asks to dismiss hair relaxer cancer claims, get lawyer.

L'Oreal says 'vague' hair-relaxer product claims should be thrown out - Affiliates from a French company that makes cosmetics L'Oreal (OREP.PA), as well as other companies in the beauty industry, have requested a U.S. judge to dismiss claims that they produced and sold harmful hair-relaxing chemicals that can cause cancer and other health issues.


In a file filed in Chicago federal court on Thursday, lawyers representing L’Oreal USA and other manufacturers have launched their first legal defence against consumers’ product-liability demands in a multidistrict lawsuit involving 14 defendants and over 250 cases.

A plethora of lawsuits were announced, and then they were consolidated within cases that were later consolidated in the Northern District of Illinois after the release in October of a National Institutes of Health study which concluded that women who utilized specific hair-relaxing products at least once every year were at higher risk of developing uterine cancer.

India’s Godrej SON Holdings and Dabur International, based in Dubai, are other defendants.

The defence lawyers who filed their joint statement in their joint filing criticized the plaintiffs’ claims for being “vague” and said they were built in “unsupported conclusions.”

The attorneys representing the plaintiffs have yet to reply to a request for clarification immediately.

The representatives for L’Oreal and the lawyers for Godrej and Dabur responded after a period of time to similar inquiries.

U.S. District Judge Mary Rowland on Thursday was set to hold an informational meeting in the case. The plaintiffs have stated that they would like a trial date set in the fall of 2024.

In a consolidated complaint, the plaintiffs complained in May that L’Oreal and others “systematically misrepresented and continue to misrepresent the significant health impacts of hair relaxer use.” The complaint alleged that L’Oreal and the other companies “exposed plaintiffs to brutally toxic products without warning.”

The plaintiffs’ lawyers claimed that the companies targeted their marketing of women of race and colour, taking “advantage of centuries of racial discrimination and cultural coercion.”

Defence lawyers presented arguments in their efforts to dispel claims that the complaint did not pinpoint specific products associated with different brands of hair relaxers. They argued that many of the companies named in the lawsuit “carry more than one product that might be considered a ‘hair straightening product.'”

The case is called In re hair Relaxer Product Liability and Marketing Practices U.S. District Court, Northern District of Illinois, No. 1:23-cv-00818.

Plaintiffs in the case: Diandra “Fu” Debrosse Zimmermann of DiCello Levitt and Fidelma Fitzgerald from Motley Rice; Michael London of Douglas & London; and Benjamin Crump of Ben Crump Law Firm

In L’Oreal USA: Dennis Ellis of Ellis George Cipollone O’Brien Annaguey and others from the Gordon Rees Scully Mansukhani law firm.


If you or your loved ones are suffering after using Hair-relaxer. Look no further. Take the Quick Case Evaluation at ZERO Cost because you may be eligible for the Compensation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Your Free

Case Evaluation!

The fee is free, you only pay when you win!

Recent News


Sharing is caring.. ?


Get Your compensation now, before it gets too late

The fee is free, you only pay when you win. Get Free Consultation from our expert lawyers.

The Justice Now Legal News

The biggest loser — workers’ compensation?

When you see a person you’ve not seen for several months, You’re probably to ask: “Gee, you look great. Have you lost weight?” The most likely answer is Ozempic Wegovy and Mounjaro. Ozempic, as well as Mounjaro, were designed for treating Type 2 diabetes; Wegovy explicitly intended to be a weight-loss drug, making use of the same semaglutide formulation used in Ozempic.

The Justice Now Legal News

Doctor asks court to toss J&J lawsuit against her over cancer research

A medical scientist has asked the court to dismiss the lawsuit Johnson & Johnson brought against her for her 2019 research on the link between cosmetic talc and cancer. She argued that her work is reliable and is protected by the freedom of speech rights.

The Justice Now Legal News

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court?

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court? – Lawyers representing plaintiffs who have signed agreements to pay a portion of their fee to chiefs of significant multidistrict litigation have to respect those agreements even if they decide to settle disputes outside the process, as per a federal appeals court ruling that week.

The Justice Now Legal News

Navy, Justice Dept. offer payouts in bid to speed up Camp Lejeune claims

The United States Department of Justice and U.S. Navy announced a program of tier-based payouts to those whom the water contamination on Marine Corps Base Camp Lejeune has harmed.

Ozempic Lawsuit

Ozempic Lawsuit: What you need to know

Ozempic Lawsuit: What you need to know – Ozempic (semaglutide) is an injection of 0.5- 2 mg, an injectable prescribed medicine used by type 2 – diabetic patients to lower the risk of heart attack, stroke, or death. Also, some of them are used for weight loss.

Bard PowerPort Catheter Lawsuit

All You Need to Know About Bard PowerPort Catheter Lawsuit: Latest Updates 2023 and Eligibility Criteria

Bard Powerport Catheter Lawsuit Updates 2023

You might also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Free Consultation?

Fill out your details and we will get back to you as soon as possible.